Could a 6-Month pill combo replace long TB treatment?
NCT ID NCT07198685
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study compares a 6-month all-oral drug regimen to the standard long treatment for people with rifampin-resistant tuberculosis. About 52 adults in China will take either the short combo (bedaquiline, delamanid, linezolid, levofloxacin) or the usual long course. The goal is to see if the shorter treatment works just as well and is safe enough to become the new standard.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREAT TO TARGET are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.